1. Making Sense of the Nonalcoholic Fatty Liver Disease Clinical Practice Guidelines: What Clinicians Need to Know.
- Author
-
Cusi, Kenneth, Budd, Jeff, Johnson, Eric, and Shubrook, Jay
- Subjects
CARDIOVASCULAR disease prevention ,PUBLIC health surveillance ,CARDIOVASCULAR diseases risk factors ,OCCUPATIONAL roles ,OBESITY ,ULTRASONIC imaging ,BIOPSY ,TIME ,NON-alcoholic fatty liver disease ,MEDICAL screening ,EVIDENCE-based medicine ,CIRRHOSIS of the liver ,HYPOGLYCEMIC agents ,MAGNETIC resonance imaging ,MEDICAL protocols ,TYPE 2 diabetes ,HEALTH care teams ,QUALITY of life ,HEALTH behavior ,WEIGHT loss ,PIOGLITAZONE ,BLOOD testing ,MEDICAL appointments ,ELECTRONIC health records ,DISEASE management ,ALGORITHMS ,BEHAVIOR modification ,COMORBIDITY ,DISEASE risk factors ,DISEASE complications - Abstract
Standards of care summarized in clinical practice guidelines for nonalcoholic fatty liver disease (NAFLD) offer clinicians a streamlined diagnostic and management approach based on the best available evidence. These recommendations have changed a great deal in recent years; today, there is a clear focus on screening for the early identification and risk stratification of patients at high risk of steatohepatitis and clinically significant fibrosis to promote timely referrals to specialty care when needed. This article reviews and provides the rationale for current guidelines for NAFLD screening, diagnosis, treatment, and monitoring and addresses barriers to providing evidence-based NAFLD care and how to overcome them. The current paradigm of care calls for primary care clinicians and specialists to work together, within a multidisciplinary care team familiar with obesity and diabetes care, to provide comprehensive management of these complex patients. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF